156 related articles for article (PubMed ID: 20740345)
21. Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.
Zhang T; Su D; Mao Z; Guo X; Wang L; Bai L
Int J Clin Exp Med; 2015; 8(5):7837-42. PubMed ID: 26221337
[TBL] [Abstract][Full Text] [Related]
22. Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Yao JC; Pavel M; Phan AT; Kulke MH; Hoosen S; St Peter J; Cherfi A; Öberg KE
J Clin Endocrinol Metab; 2011 Dec; 96(12):3741-9. PubMed ID: 21994954
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer.
Liu Y; Xu J; Jiao Y; Hu Y; Yi C; Li Q; Tong Z; Wang X; Hu L; Xiao Q; Li J; Ding K
Biomed Res Int; 2014; 2014():789575. PubMed ID: 25093184
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine differentiation in stage D2 prostate cancers.
Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of neuroendocrine markers in renal cell carcinoma.
Ronkainen H; Soini Y; Vaarala MH; Kauppila S; Hirvikoski P
Diagn Pathol; 2010 May; 5():28. PubMed ID: 20462442
[TBL] [Abstract][Full Text] [Related]
30. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
[TBL] [Abstract][Full Text] [Related]
31. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
[TBL] [Abstract][Full Text] [Related]
32. The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study.
van Krimpen C; Elferink A; Broodman CA; Hop WC; Pronk A; Menke M
Breast; 2004 Aug; 13(4):329-33. PubMed ID: 15325669
[TBL] [Abstract][Full Text] [Related]
33. [Primary superficial small cell neuroendocrine carcinoma of esophagus: clinicopathologic and immunohistochemical analysis of 15 cases].
Lu J; Lü N; Xue LY; Zou SM; Liu XY; Wen P
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):736-40. PubMed ID: 22336155
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathological features of the primary gastric neuroendocrine neoplasms].
Liang J; Liu S
Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):522-8. PubMed ID: 25327658
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
37. Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer.
Dong B; Fan L; Wang Y; Chi C; Ma X; Wang R; Cai W; Shao X; Pan J; Zhu Y; Shangguan X; Xin Z; Hu J; Xie S; Kang X; Zhou L; Xue W
Prostate; 2017 May; 77(13):1373-1380. PubMed ID: 28804908
[TBL] [Abstract][Full Text] [Related]
38. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
[TBL] [Abstract][Full Text] [Related]
39. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
[TBL] [Abstract][Full Text] [Related]
40. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
